Learned irrelevance and associative learning is attenuated in individuals at risk for psychosis but not in asymptomatic first-degree relatives of schizophrenia patients: Translational state markers of psychosis?

Schizophrenia Bulletin

Volumn 37, Issue 5, 2011, Pages 973-981

  Orosz, Ariane T ^a,b   Feldon, Joram ^a   Simon, Andor E ^b,c   Hilti, Leonie M ^d,e   Gruber, Kerstin ^c   Yee, Benjamin K ^a   Cattapan Ludewig, Katja ^b,f  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Specialised Outpatient Service for Early Psychosis   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f Sanatorium Kilchberg ^*  (Switzerland)

Author keywords

associative learning; endophenotype; latent inhibition; prodromal symptoms; selective attention; state marker

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; LEARNED IRRELEVANCE; LEARNING DISORDER; MALE; MENTAL PATIENT; PRIORITY JOURNAL; PSYCHOSIS; RELATIVE; SCHIZOPHRENIA; STATE DEPENDENT LEARNING;

ADULT; AGED; ASSOCIATION LEARNING; ATTENTION; BIOLOGICAL MARKERS; CHRONIC DISEASE; CONDITIONING, CLASSICAL; ENDOPHENOTYPES; EXTINCTION, PSYCHOLOGICAL; FEMALE; FIELD DEPENDENCE-INDEPENDENCE; HUMANS; INHIBITION (PSYCHOLOGY); MALE; MIDDLE AGED; REACTION TIME; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; VISUAL PERCEPTION; YOUNG ADULT;

EID: 80052241999     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbp165     Document Type: Article

References (49)

1. Nuechterlein KH, Dawson ME, Green MF. Informationprocessing abnormalities as neuropsychological vulnerability indicators for schizophrenia. Acta Psychiatr Scand Suppl. 1994;384:71-79. (Pubitemid 24356891)
2. McGhie A, Chapman J. Disorders of attention and perception in early schizophrenia. Br J Med Psychol. 1961;34: 103-116.
3. Lubow RE, Moore AU. Latent inhibition: the effect of nonreinforced pre-exposure to the conditional stimulus. J Comp Physiol Psychol. 1959;52:415-419.
4. Gray NS, Pilowsky LS, Gray JA, Kerwin RW. Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET. Schizophr Res. 1995;17:95-107.
5. Vaitl D, Lipp O, Bauer U, et al. Latent inhibition and schizophrenia: Pavlovian conditioning of autonomic responses. Schizophr Res. 2002;55:147-158. (Pubitemid 34310547)
6. Rascle C, Mazas O, Vaiva G, et al. Clinical features of latent inhibition in schizophrenia. Schizophr Res. 2001;51:149-161. (Pubitemid 32772848)
7. Baruch I, Hemsley DR, Gray JA. Differential performance of acute and chronic schizophrenics in a latent inhibition task. J Nerv Ment Dis. 1988;176:598-606.
8. Williams JH, Wellman NA, Geaney DP, Cowen PJ, Feldon J, Rawlins JN. Reduced latent inhibition in people with schizophrenia: an effect of psychosis or of its treatment. Br J Psychiatry. 1998;172:243-249. (Pubitemid 28123115)
9. Gray NS, Pickering AD, Hemsley DR, Dawling S, Gray JA. Abolition of latent inhibition by a single 5 mg dose of damphetamine in man. Psychopharmacology (Berl). 1992;107: 425-430.
10. Thornton JC, Dawe S, Lee C, et al. Effects of nicotine and amphetamine on latent inhibition in human subjects. Psychopharmacology (Berl). 1996;127:164-173. (Pubitemid 26298015)
11. Kumari V, Cotter PA, Mulligan OF, et al. Effects of damphetamine and haloperidol on latent inhibition in healthy male volunteers. J Psychopharmacol. 1999;13:398-405. (Pubitemid 30055185)
12. Swerdlow NR, Koob GF. Dopamine, schizophrenia, mania, and depression: toward a unified hypothesis of corticostriato-pallido-thalamic function. Behav Brain Sci. 1987;10: 197-245.
13. Cohen E, Sereni N, Kaplan O, et al. The relation between latent inhibition and symptom-types in young schizophrenics. Behav Brain Res. 2004;149:113-122. (Pubitemid 38199927)
14. Martins SA, Jones SH, Toone B, Gray JA. Impaired associative learning in chronic schizophrenics and their first-degree relatives: a study of latent inhibition and the Kamin blocking effect. Schizophr Res. 2001;48:273-289. (Pubitemid 32274322)
15. Leumann L, Feldon J, Vollenweider F, Ludewig K. Effects of typical and atypical antipsychotics on prepulse inhibition and latent inhibition in chronic schizophrenia. Biol Psychiatry. 2002;52:729.
16. Swerdlow NR, Braff DL, Hartston H, Perry W, Geyer MA. Latent inhibition in schizophrenia. Schizophr Res. 1996; 20:91-103. (Pubitemid 26387507)
17. Gal G, Barnea Y, Biran L, et al. Enhancement of latent inhibition in patients with chronic schizophrenia. Behav Brain Res. 2009;197:1-8.
18. Swerdlow NR, Stephany N, Wasserman LC, Talledo J, Sharp R, Auerbach PP. Dopamine agonists disrupt visual latent inhibition in normal males using a within-subject paradigm. Psychopharmacology (Berl). 2003;169:314-320. (Pubitemid 37255520)
19. Weiner I. The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology (Berl). 2003;169: 257-297. (Pubitemid 37264944)
20. Vaitl D, Lipp OV. Latent inhibition and autonomic responses: a psychophysiological approach. Behav Brain Res. 1997;88:85-93. (Pubitemid 27459696)
21. Gottesman II, Shields J. Genetic theorizing and schizophrenia. Br J Psychiatry. 1973;122:15-30.
22. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160:636-645. (Pubitemid 41079594)
23. Braff DL, Freedman R, Schork NJ, Gottesman II. Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr Bull. 2007;33:21-32. (Pubitemid 46026257)
24. Orosz A, Cattapan-Ludewig K, Gal G, Feldon J. Latent inhibition and learned irrelevance paradigms: a convenient way to assess information processing deficits in schizophrenia. In: Almann KV, ed. Schizophrenia Research Trends. New York, NY: Nova Science Publishers, Inc; 2008:137-161.
25. Baker AG, Mackintosh NJ. Preexposure to the CS alone, US alone, or CS and US uncorrelated: latent inhibition, blocking by context, or learned irrelevance? Learn Motiv. 1979;10: 278-294.
26. Baker AG, Mackintosh NJ. Excitatory and inhibitory conditions following uncorrelated presentations of CS and US. Anim Learn Behav. 1977;5:315-319. (Pubitemid 8184824)
27. Bonardi C, Hall G. Learned irrelevance: no more than the sum of CS and US preexposure effects? J Exp Psychol Anim Behav Process. 1996;22:183-191.
28. Bonardi C, Yann OS. Learned irrelevance: a contemporary overview. Q J Exp Psychol B. 2003;56:80-89. (Pubitemid 37353304)
29. Orosz AT, Feldon J, Gal G, Simon AE, Cattapan-Ludewig K. Deficient associative learning in drug-naive first-episode schizophrenia: results obtained using a new visual withinsubjects learned irrelevance paradigm. Behav Brain Res. 2008;193:101-107.
30. Young AM, Kumari V, Mehrotra R, et al. Disruption of learned irrelevance in acute schizophrenia in a novel continuous within-subject paradigm suitable for fMRI. Behav Brain Res. 2005;156:277-288. (Pubitemid 39576068)
31. Gal G, Mendlovic S, Bloch Y, et al. Learned irrelevance is disrupted in first-episode but not chronic schizophrenia patients. Behav Brain Res. 2005;159:267-275. (Pubitemid 40462502)
32. Stieglitz RD. Diagnostik und Klassifikation psychischer Störungen. Göttingen, Germany: Hogrefe; 1998.
33. Wittchen HU, Fydrich T. Strukturiertes Klinisches Interview für DSM-IV. Manual zum SKID-I und SKID-II. Göttingen, Germany: Hogrefe; 1997.
34. Raine A. The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull. 1991;17:555-564.
35. Miller TJ, McGlashan TH, Woods SW, et al. Symptom assessment in schizophrenic prodromal states. Psychiatr Q. 1999;70:273-287.
36. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 4th ed.Washington, DC: American Psychiatric Association; 1994.
37. Orosz A, Feldon J, Gal G, Simon A, Cattapan-Ludewig K. Repeated measurements of learned irrelevance by a novel within-subject paradigm in humans. Behav Brain Res. 2007; 180:1-3. (Pubitemid 46671561)
38. Cadenhead KS, Swerdlow NR, Shafer KM, Diaz M, Braff DL. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits. Am J Psychiatry. 2000;157:1660-1668.
39. Kumari V, Das M, Zachariah E, Ettinger U, Sharma T. Reduced prepulse inhibition in unaffected siblings of schizophrenia patients. Psychophysiology. 2005;42:588-594. (Pubitemid 43942839)
40. Price GW, Michie PT, Johnston J, et al. A multivariate electrophysiological endophenotype, from a unitary cohort, shows greater research utility than any single feature in the Western Australian family study of schizophrenia. Biol Psychiatry. 2006;60:1-10.
41. Louchart-de la CS, Nkam I, Houy E, et al. A concordance study of three electrophysiological measures in schizophrenia. Am J Psychiatry. 2005;162:466-474. (Pubitemid 40343913)
42. Cadenhead KS, Light GA, Shafer KM, Braff DL. P50 suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment. Biol Psychiatry. 2005;57:1504-1509. (Pubitemid 40805379)
43. Quednow BB, Frommann I, Berning J, Kuhn KU, Maier W, Wagner M. Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia. Biol Psychiatry. 2008;64:766-773.
44. Braff DL. Information processing and attention dysfunctions in schizophrenia. Schizophr Bull. 1993;19:233-259. (Pubitemid 23183147)
45. Pearce JM, Hall G. A model for Pavlovian learning: variations in the effectiveness of conditioned but not of unconditioned stimuli. Psychol Rev. 1980;87:532-552.
46. Bennett CH, Maldonado A, Mackintosh NJ. Learned irrelevance is not the sum of exposure to CS and US. Q J Exp Psychol B. 1995;48:117-128.
47. Mackintosh NJ. A theory of attention: variations in the associability of stimuli with reinforcement. Psychol Rev. 1975;82:276-298.
48. Mackintosh NJ. Stimulus selection: learning to ignore stimuli that predict no change in reinforcement. In: Hinde RA, Hinde JS, eds. Constraints on Learning. London, UK: Academic Press; 1973:75-96.
49. Schmidt-Hansen M, Killcross AS, Honey RC. Latent inhibition, learned irrelevance, and schizotypy: assessing their relationship. Cogn Neuropsychiatry. 2009;14:11-29.